Hiramani Dhungana
Overview
Explore the profile of Hiramani Dhungana including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
436
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wu Y, Lehtonen S, Trontti K, Kauppinen R, Kettunen P, Leinonen V, et al.
Fluids Barriers CNS
. 2024 Sep;
21(1):78.
PMID: 39334385
Background: Patients with Alzheimer's disease (AD) frequently present with cerebral amyloid angiopathy (CAA), characterized by the accumulation of beta-amyloid (Aβ) within the cerebral blood vessels, leading to cerebrovascular dysfunction. Pericytes,...
2.
Keuters M, Keksa-Goldsteine V, Rolova T, Jaronen M, Kettunen P, Halkoluoto A, et al.
Sci Rep
. 2024 Aug;
14(1):17949.
PMID: 39095453
Stroke is a leading cause of permanent disability worldwide. Despite intensive research over the last decades, key anti-inflammatory strategies that have proven beneficial in pre-clinical animal models have often failed...
3.
Keuters M, Antila S, Immonen R, Plotnikova L, Wojciechowski S, Lehtonen S, et al.
Transl Stroke Res
. 2024 Jun;
PMID: 38822994
Timely relief of edema and clearance of waste products, as well as promotion of anti-inflammatory immune responses, reduce ischemic stroke pathology, and attenuate harmful long-term effects post-stroke. The discovery of...
4.
Scoyni F, Sitnikova V, Giudice L, Korhonen P, Trevisan D, Hernandez de Sande A, et al.
Cell Rep
. 2024 Mar;
43(3):113862.
PMID: 38446664
Brain functionality relies on finely tuned regulation of gene expression by networks of non-coding RNAs (ncRNAs) such as the one composed by the circular RNA ciRS-7 (also known as CDR1as),...
5.
Jantti H, Oksanen M, Kettunen P, Manta S, Mouledous L, Koivisto H, et al.
Cells
. 2022 Dec;
11(24).
PMID: 36552881
The ΔE9 mutation causes a familial form of Alzheimer's disease (AD) by shifting the processing of amyloid precursor protein (APP) towards the generation of highly amyloidogenic Aβ42 peptide. We have...
6.
Valimaki N, Bakreen A, Hakli S, Dhungana H, Keuters M, Dunlop Y, et al.
Stroke
. 2022 Sep;
53(10):3192-3201.
PMID: 36111544
Background: Species-specific differences in astrocytes and their Alzheimer disease-associated pathology may influence cellular responses to other insults. Herein, human glial chimeric mice were generated to evaluate how Alzheimer disease predisposing...
7.
Koskuvi M, Lehtonen S, Trontti K, Keuters M, Wu Y, Koivisto H, et al.
Glia
. 2021 Dec;
70(4):650-660.
PMID: 34936134
Previous studies have implicated several brain cell types in schizophrenia (SCZ), but the genetic impact of astrocytes is unknown. Considering their high complexity in humans, astrocytes are likely key determinants...
8.
Keuters M, Keksa-Goldsteine V, Dhungana H, Huuskonen M, Pomeshchik Y, Savchenko E, et al.
Sci Rep
. 2021 Feb;
11(1):3518.
PMID: 33568697
Lipid peroxidation-initiated ferroptosis is an iron-dependent mechanism of programmed cell death taking place in neurological diseases. Here we show that a condensed benzo[b]thiazine derivative small molecule with an arylthiazine backbone...
9.
Loppi S, Korhonen P, Bouvy-Liivrand M, Caligola S, Turunen T, Turunen M, et al.
Aging Cell
. 2020 Dec;
20(1):e13287.
PMID: 33369048
Ischemic stroke, the third leading cause of death in the Western world, affects mainly the elderly and is strongly associated with comorbid conditions such as atherosclerosis or diabetes, which are...
10.
Kolosowska N, Gotkiewicz M, Dhungana H, Giudice L, Giugno R, Box D, et al.
J Neuroinflammation
. 2020 Jun;
17(1):194.
PMID: 32560730
Background: Ischemic stroke is a devastating disease without a cure. The available treatments for ischemic stroke, thrombolysis by tissue plasminogen activator, and thrombectomy are suitable only to a fraction of...